Tafamidis Reduces Mortality Rates In Cardiomyopathy Patients

Tafamidis Reduces Mortality Rates In Cardiomyopathy Patients Overview The study explored the effectiveness of tafamidis in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) across varying levels of left ventricular ejection fraction (LVEF). Conducted as part of the phase 3 ATTR-ACT trial and its subsequent long-term extension (LTE) study, patients were initially randomized to

Heart Transplant Patient Confessions About Life Quality

Heart Transplant Patient Confessions About Life Quality Overview Survival rates following heart transplantation (HTx) have markedly improved over recent decades, underscoring the need to examine the long-term quality of life (QoL) for these patients. This study assessed the QoL of 75 individuals who had survived 20 to 31 years (average 24.9 years)

Spotlight On Heart Failure Pathophysiology: Coronary Microvascular Dysfunction

Spotlight On Heart Failure Pathophysiology: Coronary Microvascular Dysfunction Overview  In the comprehensive investigation of heart failure with preserved ejection fraction (HFpEF), a multitude of underlying mechanisms were explored, among which coronary microvascular dysfunction (CMD) emerged as a pivotal contributor to the pathophysiology. Through a rigorous systematic review and meta-analysis, the research aimed

Chronic Hyponatremia in Acute Heart Failure

Chronic Hyponatremia in Acute Heart Failure Overview This study aimed to comprehensively assess hyponatremia in patients with acute heart failure (AHF), focusing on its prevalence, associations, hospital course, and post-discharge outcomes. The research analyzed a cohort of 8,298 AHF patients from the European Society of Cardiology Heart Failure Long-Term Registry, regardless of

Tafamidis Reduces Mortality Rates In Cardiomyopathy Patients